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Abstract. A study was undertaken tohelp us reach a better 
understanding of the tumor-infiltrating pattern of lymphoid 
cells and in particular of monocyte-derived cells, namely 
the CD68 +, acid-phosphatase-expressing scavenger mac- 
rophages and the MHC-class-II- and S100-antigen-pre- 
senting dendritic cells in head and neck squamous-cell 
carcinoma. In the stroma of the tumors distinctive small 
fields of lymphocytes were found, the T cell areas of these 
fields being intermingled with dendritic ells. Intra-epithe- 
lial dendritic ell infiltration was low. The infiltrative pat- 
tern of macrophages was similar to patterns described in 
earlier studies with substantial stromal invasion and incon- 
sistent intra-epithelial invasion, but small granuloma-like 
structures of CD68 + macrophage-like c lls, found in the 
stroma of tumors, have not been reported before. The his- 
tochemical localization of the tumor-infiltrated dendritic 
cells and macrophages supports the view that the former 
cells are involved in the sensitization to tumor antigens, 
whereas the latter cells are involved in tumor cytotoxic- 
ity/scavenging of tumor cell debris. Although it has been 
shown in the past that transmembranal (TM) factors 
(pl5E-like factors) present in the serum and tumor of 
patients with cancer of the head and neck have suppressive 
effects on monocyte/macrophage/dendritic cell function, a
relationship between the intensity of epithelial staining for 
TM factors and the infiltrative pattern of monocytes/mac- 
rophages/dendritic cells could not be demonstrated. 
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Introduction 
There is experimental evidence that the cell-mediated im- 
lnune system plays an important role in the defence against 
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head and neck squamous carcinoma cells [4, 8, 9, 15, 22]. 
Cell-mediated immune functions are executed by T lym- 
phocytes, monocytes, macrophages and dendritic ells. It is 
therefore of relevance that defects in the function of these 
cells have been described in patients with head and neck 
cancer. 
Dendritic cells play a role in tumor defence by pre- 
senting tumor-associated antigens to the immune system. 
Dendritic ells are monocyte-derived cells, with a distinc- 
tive morphology and a characteristic marker pattern in 
immunohistology. The cell shows long cytoplasmic veils 
or dendrites, has a kidney-shaped nucleus and usually re- 
acts strongly with MHC-class-II-directed antibodies 
amongst which are L25 and RFD1. The cell is also often 
positive for the protein S100. Dendritic cells have a weak 
expression (sometimes only in the form of a paranuclear 
spot) of CD68, CD14 and of the enzyme acid phosphatase. 
To execute its antigen-presenting function, the dendritic 
cell forms clusters with lymphocytes and it is therefore of 
importance that, in patients with head and neck cancer, 
the capability of blood dendritic cells to form clusters 
with allogenic lymphocytes has been described as im- 
paired [19]. 
Macrophages are also monocyte-derived cells and 
mainly have a killer and scavenger function. Macrophages 
are strongly positive for CD68, and the enzyme acid 
phosphatase; occasionally, they are positive for MHC 
class II markers. Morphologically, they are large, rounded 
cells lacking long cytoplasmic protrusions. Defects in the 
tumoricidal capacity of macrophages have also been re- 
ported in patients with head and neck cancer [4.]. 
The majority of reports on the infiltration of lymphoid 
cells into head and neck tumors deal with the infiltration of 
lymphocytes. Reports on the pattern of infiltration of mono- 
cytes, macrophages and dendritic cells are scarce. It has 
been described that patients with a dense infiltration of 
S100-positive dendritic ells in nasopharyngeal c rcinoma 
are likely to survive longer than those without [16]. No such 
correlation appears to exist, however, between the density 
of lysosome-positive macrophage infiltration in or around 
tumor nests and the prognosis or stage of the tumor [16]. 
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Table 1. Monoclonal antibodies 
Epitope Antibody Dilution Specificity Source 
RFD1 1 : 1000 Active dendritic ells and subset of B cells Kindly provided by L. Poulter, London 
(class-II-MHC-associated antigen) 
1:1000 Dendritic eils and B cells 
1 : 500 Dendritic ells (mainly intra-epithelial) 
Ki-M7 1 : 200 Macrophages ( trong cytoplasmic expression) 
LeuM3 1 : 500 Monocytes, macropbages 
Leu4 1 : 60 Immature and mature functional T cells 
CLB-B4 1 : 25 B ceils 
L25 
S100 
CD68 
CD14 
CD3 
CD19 
4F5 1:200 pl5E 
Kindly provided by Ishii, Sapporo 
Dakopatts, Glostrup 
Behring, Marburg, Germany 
Becton Dickinson, San Jose, Calif. 
Becton Dickinson, San Jose, Calif. 
Central Laboratory of the Blood 
Transfusion Service, Amsterdam 
Kindly provided by G. J. Cianciolo 
The first objective of  this study is to give a detailed 
analysis of  the pattern of  tumor infiltration by macro- 
phages, defined as large rounded cells strongly positive for 
CD68 and CD14 and by dendritic cells defined as stellate- 
shaped cells positive for L25, RFD1 and S 100. The spatial 
relationship between dendritic cells, macrophages and 
malignant epithelial cells and the spatial relationship of 
these cells to infiltrating T lymphocytes and B lympho- 
cytes was studied as well. 
Carcinoma cells, including head and neck squamous 
carcinoma cells are capable of producing factors that exert 
a variety of suppressive ffects on different ypes of  im- 
mune cells. Some of these tumor factors also demonstrate 
a suppressive effect on the chemotactic capability of mono- 
cytes/macrophages and the capability of  dendritic cells to 
form clusters with allogeneic lymphocytes. The factors 
produced show a structural and functional homology with 
a retroviral transmembranal (TM) protein called p l5E  [5], 
hence the name pl5E- l ike factors. It is not yet clear if any 
relationship exists between the degree of TM factor expres- 
sion in head and neck cancer cells in vivo and the infiltra- 
tion pattern of macrophages and dendritic cells in and 
around the malignant cells. We therefore also studied the 
relationship of  the immunohistomorphological expression 
of  this TM factor in head and neck squamous carcinoma 
cells and the pattern of  infiltration of  macrophages and 
dendritic ells. 
Materials and methods 
Patients and tissues. Samples of fresh tumor tissue were obtained from 
surgically removed tumors of 18 patients with squamous-cell carcinoma 
of the head and neck; 7 carcinomas of the oral cavity, 6 oropharyngeai 
carcinomas, 3 carcinomas of the hypopharynx and 2 of the larynx were 
included. Small representative tissue parts of the removed tumor were 
frozen in liquid nitrogen and stored at -80 ~ C. Tissue was taken from the 
central solid part of the tumor to avoid the effect of superficial bacterial 
infection on lymphoid cell infiltration; signs of infection were not present 
in any of the tumor biopsies. 
Immunohistology. Serial 6-gin cryostat sections were cut and mounted 
on slides, air-dried and fixed in acetone. Normal rabbit serum 
(Dakopatts, Copenhagen, Denmark) was added and gently removed by 
tapping the slides after 15 rain. The slides were thereafter incubated for 
1 h at room temperature with the monoclonal ntibodies li ted in Table 1, 
to identify the various infiltrating lymphoid cells. All antibodies were 
diluted in phosphate-buffered saline (PBS), pH 7.4 enriched with 1% 
bovine serum albumin (Sigma, St. Louis, Mo.) before incubation. After 
incubation the sections were gently rinsed with PBS to wash away excess 
monoclonal ntibodies for at least 15 rain and thereafter incubated with 
horseradish-peroxidase-conjugated r bbit anti-(mouse Ig) serum 
(Dakopatts, Copenhagen, Denmark) with 1% human pooled serum for 
30 min. Subsequently, the sections were rinsed with PBS for another 
15 min and stained for peroxidase activity with 3.3'-diaminobenzidine 
tetrahydrochloride (Sigma, St. Louis, Mo.) in PBS containing 0.01% 
H202. The sections were rinsed in tap water, counterstained with he- 
matoxylin for 30 s, dehydrated and mounted in malinol. All sections 
were additionally tested for acid phosphatase activity with naphthol 
AS-BI phosphatase assnbstrate and hexazotized pararosaniline asdia- 
zonium salt. 
The slides were studied by two of the authors (J. K. and H. D.) using 
a Zeiss light microscope at various magnifications. Tumors were studied 
for morphology and lymphoid cell infiltration. 
Cell infiltration was semiquantitavely scored as follows: -, no cells 
present; +_, few scattered cells present; +, diffuse compartmental infiltra- 
tion by solitary cells; ++, marked compartmental ce l infiltration with no 
apparent organization; +++, heavy cell accumulation with a clear infiltra- 
tion architecture; ++++, massive clotting of cells. 
Results 
Studying the immunohistological appearance of specimens 
of  head and neck carcinoma, we could clearly make a 
distinction between areas composed of malignant 
squamous epithelial cells (parenchymal tumor nests) and 
areas of  surrounding stromal connective tissue. 
In the stromal connective tissue three types of  lymphoid 
cell infiltration could be identified: (a) an infiltration by 
scattered and mostly single lymphoid cells. (b) small areas 
of densely packed lymphoid cells with a certain degree of 
organization and (c) small granuloma-like structures. The 
first type of stromal infiltration was the most predominant. 
In the malignant epithelial areas (the tumor nests) there 
was also a scattered infiltration of  single lymphoid cells. 
The infiltration pattern of scattered, mostly single 
lymphoid cells in the stromal compartment ofthe tumor 
(Table 2) 
Many CD68 + large cells were present, which morphologi- 
cally varied from monocyte-l ike cells to very large, round, 
strongly staining macrophages. A similar pattern of  distri- 
bution was seen for CD14 + cells. 
Table 2. Lymphoid cell infiltration in the stromal compartment and into 
malignant epithelial areas 
Ceils Areas of Areas of dense Granulo- Cancer 
scattered packed matons nest 
lymphoid cell lymphoid cell structures infiltra- 
infiltration accumulations tion 
Dendritic cells 
N100 
CDla  
RFD 1/L25 
Macrophages 
CD68 
CD14 
T cells 
CD3 
B cells 
CD19 
+ ++ - + 
++ ++ + + to + 
+++ +++ (particularly in ++++ ++ 
++ ++ B cell areas) ++ + 
+ to ++ +++ to ++++ - _+ 
- to  +++ - - 
RFD1 + stellate-shaped cells were also clearly present, 
however, generally in fewer numbers than the CD68 + mac- 
rophages. The RFD 1 + dendritic ells were also positive for 
other MHC class II molecules (as identified with the mAb 
OKla); the cells were, however, less positive for L25 and 
markedly less positive for CDla and the S100 protein 
(though they were positive). 
The number of scattered single CD3 + lymphocytes 
varied from tumor to tumor, there being no apparent rela- 
tionship between CD3 + lymphocyte infiltration and the 
differentiation grade of the tumor. A large proportion of the 
small round CD3+ T lymphocytes were also positive for 
MHC class II and RFD1. CD19 § B cells were not present 
in this type of infiltrate. 
Areas of dense, packed lymphoid cells in the stromal 
compartment (Table 2) 
Small areas of dense packed lymphoid cell infiltration were 
present in 8/18 of the studied tumor specimens (Fig. 1). 
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These dense lymphoid cell areas were randomly localized 
and not particularly located in the vicinity of, or at the 
borders of the epithelial tumor nests. Inter-tumoral varia- 
tion was extensive, but intra-tumoral variation was limited 
with respect to the number of such areas. 
The areas of dense lymphoid cells had a certain degree 
of architecture with identifiable areas of CD3 + T cell accu- 
mulation and, in an occasional tumor, a central area of 
CD19+ B cells. These latter areas are reminiscent of early 
B cell follicles. RFD1 + and L25 § stellate-shaped cells were 
strongly represented within the CD3 + T cell areas. In the 
S100 staining, the presence of dendritic cells within the 
T cell zones was also obvious; CDla positivity was, how- 
ever, almost absent in these areas. With respect o the 
central B cell areas it was clear that in particular CD68 § 
and CD14 § monocytes/macrophages could be identified 
within these areas. 
Granulomatous structures within the stromal 
compartment (Table 2) 
Granulomatous structures were mostly small and always 
located near the borders of the malignant epithelial areas. 
They were present in 7/18 of the specimens tudied 
(Fig. 2). The presence or absence of these lymphoid cell 
structures was again not dependent on tumor differentia- 
tion, nor was there a relationship with the presence of the 
dense, packed lymphoid cell accumulations. The cells 
forming the granulomas were strongly positive for the 
macrophage marker CD68, while being only weakly posi- 
tive for CD14, RFD1 and L25. T lymphocytes (CD3+) and 
B lymphocytes (CD19 +) were not present within these 
structures. 
Scattered infiltration of lymphoid cells in the 
parenchymal areas of malignant epithelial cells (Table 2) 
CD68 + macrophage infiltration was markedly present in 
most tumors, within the parenchymal reas of malignant 
epithelial cells, though, less than in the stromal areas 
Fig. 1. Area of dense CD3 + lymphoid cell 
infiltration in stromal compartment. Magnifi- 
cation: 36 • 
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Fig. 2. Granulomatous CD68 + structure 
within the stromal compartment. Note also 
intratumoral CD68 + macrophage infiltration. 
Magnification: 36 x 
Fig. 3. S 100 + dendritic ell infikration into 
malignant epithelial area and surrounding 
stroma. Magnification: A 80 x ; B 200 x 
(Fig. 2). The pattern of infiltration between the different 
tumors, but also within an individual tumor was often 
variable. There was a stronger and more diffuse infiltration 
in poorly differentiated tumors, the CD68 § macrophages 
often reaching the central areas of the tumor nests. In 
well-differentiated tumor tissue the infiltration was less 
extensive, the CD68 § macrophages staying closer to the 
outer zones of the tumor. A similar pattern of CD14 + 
monocyte/macrophage infiltration was found although 
numbers of such monocytes/macrophages wereconsider- 
ably lower. Very few CDla § RFD1 + and L25 + cells with a 
classic dendritic ell morphology were present in well- 
differentiated malignant epithelial areas; however, in 
poorly differentiated tumors more RFDI§ cells were iden- 
tifiable. The few infiltrating dendritic ells in the well- 
differentiated tumors stayed at the borders of the tumor 
nests. Intra-epithelial infiltration of S100 § dendritic ells 
was considerable and comparable to stromal S100 + den- 
dritic cell infiltration (Fig. 3 A, B). 
CD3 § lymphocytes also basically infiltrated the outer 
zones of the tumor nests (similar to the CD 1 a§ RFD 1 + and 
L25+ dendritic cells in the well-differentiated tumors), 
again in considerably ower numbers compared to their 
infiltration into the stromal compartment. Infiltration of 
CD3 § lymphocytes into poorly differentiated tumors was 
more extensive than into well-differentiated tumors. 
CD19 § B cells were virtually absent from these malignant 
epithelial areas. 
In all tumors, the malignant epithelial structures stained 
clearly positive for the anti-p 15E antibody 4F5 to an extent 
that mostly depended on the differentiation grade of the 
tumor. Expression varied from weak to strong between 
tumors and sometimes even within tumors. There was, 
however, no relationship between the intensity of pl5E 
expression and the severity of lymphoid cell infiltration of 
any kind. 
Discussion 
The dendritic ells in the antigen-presenting accessory cell 
par excellence [2, 10, 11]. The cell exposes on its long 
cytoplasmic extensions a high density of MHC class I and 
II molecules (the antigen-presenting molecules), and ac- 
tively seeks contact with surrounding cells including lym- 
phocytes to present the antigens. During this antigen pre- 
sentation the cell forms cell clusters with the lymphocytes. 
Apart from this cluster formation, in which a micro-en- 
vironment suitable for antigen presentation is created, the 
dendritic ell is capable of producing aseries of cytokines 
that activate T and B lymphocytes. Dendritic ells do not 
only occur in the T cell areas of spleen and lymph nodes as 
so-called interdigitating dendritic ells, but also occur as 
the Langerhans cells in the epidermis and dermis of the 
skin and mucosal surfaces. It is now generally accepted 
that the dendritic ells of the skin and mucosal surfaces 
travel via the lymph to the draining lymph nodes, trans- 
porting antigens from the periphery to the lymphoid organs 
to present the antigens to lymphocytes toinitiate inmmne 
reactivity in the lymphoid spleen [12]. 
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Although no specific mAb for the staining of dendritic 
cells exists, RFD 1 and L25 can be used adequately (togeth- 
er with classical morphological characteristics such as 
shape) to identify the lymphoid endritic ells present in 
the T cell areas of spleen and lymph nodes. S 100 and CD1 
are reasonably characteristic for the Langerhans cells of the 
skin (these marker proteins are also present in some den- 
dritic cells of the lymphoid tissues). 
In this study we found that RFD1 + and L25 + dendritic 
cells were markedly present within the T cell areas of lym- 
phoid cell accumulations present in the strornal compart- 
ment between tumor nests. These dendritic ells were vir- 
tually negative for the markers S100 and CDI. The posi- 
tion of these lymphoid endritic ells indicates their an- 
tigen-presenting function and suggests an active stimula- 
tion of the immune system in the dense lymphoid areas in 
at least some tumors. RFD 1+ and L25 + dendritic ells were 
also diffusely present in the stromal compartment, but only 
scarcely within the well-differentiated malignant epithelial 
areas. The intra-epithelial infiltration of S100 + dendritic 
cells was considerable and comparable to stromal S100§ 
dendritic ell infiltration. This observation is in agreement 
with the classical notion that intra-epithelial dendritic ells, 
often referred to as Langerhans cells, are mainly S 100-pos- 
itive, and our data thus suggest a more Langerhans-cell- 
like characteristic of the dendritic ells that have infiltrated 
the malignant epithelial cell areas. 
Our observations are hence by and large in agreement 
with the study of Nomori et al. [16] on nasopharyngeal 
carcinoma. These authors found S 100 § dendritic ells pri- 
marily located within the tumor nests, and found few of 
these cells in the surrounding connective tissue. Similar 
findings have been reported by Nakano et al. [14] in 
squamous-cell carcinoma of the uterine cervix; they de- 
scribed that the S 100 + dendritic ells were mainly located 
in between the malignant epithelial tumor cells. In gastric 
adenocarcinoma Tsujitani et al. [20, 21] described clusters 
of S100+ dendritic ells in the tumor stroma s well as an 
infiltration in between the cancer cells. In all these studies 
S100 only was used to identify dendritic ells, and it is 
therefore difficult o draw any conclusions concerning the 
dendritic ells that are negative for this protein (the major- 
ity of the dendritic ells present in T cell areas of the focal 
lymphocyte infiltrates found in our study). It is of impor- 
tance to note that all three of the above-mentioned authors 
correlated a marked endritic ell infiltration with a better 
prognosis. These findings indicate that dendritic ells prob- 
ably play a more important role in the immune defense 
against cancer than do scavenger macrophages. The num- 
ber of patients and length of follow-up period in our study 
are so far insufficient for correlation studies, but later re- 
ports will address this issue. 
Macrophages with a scavenger and cytotoxic function 
are mainly involved in the efferent arm of t]he immune 
response. Such cells are markedly positive for CD68 and 
lysosomal enzymes such as acid phosphatase. In our study 
CD68 + macrophages were strongly represented both 
within the connective tissue compartment as well as in the 
malignant epithelial areas; however, the infiltration i to the 
latter area varied widely between the various tumors, some 
showing hardly any, others howing massive intra-epitheli- 
36 
al invasion. The latter pattern may indicate a stronger cyto- 
toxic response to these tumors; however, histologically 
clear tumor cell destruction was not seen. 
Ki-M7 (a monoclonal antibody that reacts with CD68, 
used in our study) stains mature CD68 + macrophages [7]. 
Despite the fact that macrophages have in vivo and in vitro 
a cytotoxic/cytolytic effect when activated by lymphokines 
or bacterial products, their precise role in tumor immunol- 
ogy in vivo remains uncertain. Cameron and Stromberg [4] 
found a defect in tumoricidal capacity in head and neck 
cancer; half of the patients in their study possessed macro- 
phages that were non-cytotoxic toward tumor cells in vitro. 
Allen [1] found no histological evidence for a cytotoxic 
role of macrophages in colorectal tumors. In murine sar- 
comas and carcinomas, tumor-associated macrophages 
were even thought o stimulate tumor growth [13]. It has 
been suggested [17] that tumor cells may become insensi- 
tive to cytolysis in vivo by activated macrophages by 
building up a resistance to tumor necrosis factors, which 
are mediators in the lymphokine activation of macro- 
phages. 
Neuchrist et al. [15], also using immunohistology, 
showed that most tumor-infiltrating macrophages are of a 
functionally mature phenotype. The distribution these 
authors described is similar to our findings, with an exten- 
sive stromal macrophage invasion and some infiltration 
into the areas of the malignant epithelial cells (with a wide 
inter-tumoral variation). These authors, however, did find 
(in contrast to us) a correlation between the extent of CD3 § 
lymphocyte infiltration and the infiltration by macro- 
phages. Others have also stressed the important role of 
T-cell-activating macrophages in direct tumor defence 
[23]. It must be noted, however, that Neuchrist et al. used 
markers uch as a-HLA-DR, a-Fcy receptors I, II, III, and 
Rm3/1 to identify the macrophages. We consider HLA- 
DR§ ceils not as classical macrophages but, when stellate- 
shaped, as dendritic ells; this might explain the discrepan- 
cy between our results and those of others. We did find a 
relationship between the infiltration of HLA-DR + dendritic 
cells and T cells. 
In nasopharyngeal carcinoma Nomori [16] found that 
most lysozyme-antibody-stained macrophages surrounded 
the tumor nests although he did not describe the granulo- 
matous tructures of our study. In the granulomatous struc- 
tures present in the stromal compartment close to the tumor 
nests all cells were strongly positive for CD68, in fact the 
histology suggests to us that these areas were almost pre- 
dominantly composed of large, fused macrophages 
supporting the classically held view that granuloma's are 
mainly involved in the degradation of persistent antigens or 
non-degradable materials. A marked intra-epithelial infil- 
tration of macrophages in adenocarcinoma of the stomach 
and in breast cancer was found by Tsujitani et al. [20, 21] 
and Zuk et al. [24]. We also found a marked infiltration 
with such cells mainly in poorly differentiated head and 
neck squamous-cell carcinomas. 
Ciauciolo [6] demonstrated in 1980 the presence of a 
low-molecular-mass (low-Mr) factor in both animal as well 
as human cancers. This factor had an inhibitory effect on 
monocyte chemotaxis and appeared later to be absorbable 
by any of three different mAb to a retroviral capsular 
protein, namely p15E. Tan [18] showed that the pl5E-l ike 
low-Mr factors were also present in the tumors of patients 
with head and neck cancer as well as in the serum of these 
patients. The pl5E-like factors, presently called TM fac- 
tors, have a suppressive ffect not only on monocyte 
chemotaxis but also on the function of various cells of the 
immune system. The factors inhibit IL-2 dependent T cell 
proliferation, they inhibit the blastogenic responses to mi- 
togens and antigens, they suppress the natural killer cell 
activity, they hamper the clustering capacity of dendritic 
cells and they suppress the respiratory burst of human 
monocytes. All tumors in our study showed positivity for 
the anti-TM-factor mAb 4F5. However, no relationship 
between p l5E expression and any particular infiltrative 
pattern could be demonstrated. In our earlier report we 
were able to correlate tumor infiltration with chemotactic 
ability [3]. Important o note is that positive staining of 
cancer cells for anti-TM-factor mAb does not necessarily 
mean that the tumor produces or secretes these factors. 
Furthermore, recent work in our group [19] has suggested 
that the anti-TM-factor mAb may not be as specific for 
p l5E as was believed earlier: it has been shown that these 
mAb cross-react with interferon o~ and possibly other cy- 
tokines. Future work will address this matter. 
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